HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Deepa Bhojwani Selected Research

EZN 3042

8/2014A phase I study of EZN-3042, a novel survivin messenger ribonucleic acid (mRNA) antagonist, administered in combination with chemotherapy in children with relapsed acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Deepa Bhojwani Research Topics

Disease

40Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
06/2022 - 01/2003
19Leukemia
10/2022 - 01/2003
13Neoplasms (Cancer)
10/2022 - 01/2003
9Residual Neoplasm
01/2021 - 01/2009
7Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 09/2011
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2022 - 01/2007
4Lymphoma (Lymphomas)
10/2022 - 08/2014
2Capillary Leak Syndrome
01/2021 - 10/2017
2Neurologic Manifestations (Neurological Manifestations)
11/2020 - 09/2011
2Pancreatitis
01/2018 - 01/2016
2Obesity
01/2018 - 09/2011
2Leukoencephalopathies
10/2016 - 03/2014
2Philadelphia Chromosome
05/2014 - 01/2009
1Cytopenia
01/2022
1Down Syndrome (Down's Syndrome)
01/2022
1Myeloid Leukemia (Leukemia, Myelocytic)
01/2022
1Hyperbilirubinemia
01/2022
1Neuroinflammatory Diseases
12/2021
1Seizures (Absence Seizure)
07/2021
1Blindness (Hysterical Blindness)
07/2021
1B-Cell Leukemia (Leukemia, B Cell)
01/2020
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2019
1Venous Thromboembolism
01/2018
1Weight Gain
10/2017
1Hemolytic-Uremic Syndrome
10/2017
1Thrombotic Microangiopathies
10/2017
1Hypoalbuminemia
10/2017
1Eosinophilia
10/2017
1Disease Resistance
09/2017
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2016
1Glucocorticoid Receptor Deficiency
06/2015
1Osteonecrosis (Kienbock's Disease)
02/2015
1Hemorrhage
08/2014

Drug/Important Bio-Agent (IBA)

6Biological ProductsIBA
09/2017 - 01/2003
5GlucocorticoidsIBA
12/2021 - 01/2009
4blinatumomabIBA
01/2022 - 12/2016
4DNA (Deoxyribonucleic Acid)IBA
01/2021 - 05/2006
3DecitabineFDA Link
10/2022 - 01/2020
3VorinostatFDA Link
10/2022 - 01/2020
3Chimeric Antigen ReceptorsIBA
04/2022 - 01/2018
3Inotuzumab OzogamicinIBA
01/2022 - 01/2019
3RNA (Ribonucleic Acid)IBA
01/2022 - 08/2014
3Pharmaceutical PreparationsIBA
01/2022 - 01/2020
3Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2003
3immunotoxin HA22IBA
01/2021 - 10/2017
3Tyrosine Kinase InhibitorsIBA
10/2017 - 01/2009
2Cytarabine (Cytosar-U)FDA LinkGeneric
10/2022 - 01/2012
2Asparaginase (Elspar)FDA Link
06/2022 - 01/2016
2Clofarabine (Clolar)FDA Link
01/2021 - 01/2012
2Transcription Factors (Transcription Factor)IBA
01/2021 - 10/2013
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 01/2012
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 10/2017
2Etoposide (VP 16)FDA LinkGeneric
01/2021 - 01/2012
2Methotrexate (Mexate)FDA LinkGeneric
11/2020 - 03/2014
2Immunotoxins (Immunotoxin)IBA
01/2020 - 10/2017
2ProteomeIBA
01/2007 - 05/2006
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2022
1fludarabineIBA
10/2022
1BilirubinIBA
06/2022
1EnzymesIBA
06/2022
1LigandsIBA
01/2022
1Protein Isoforms (Isoforms)IBA
01/2022
1Integrin alpha4beta1 (VLA-4)IBA
01/2022
1CD19 AntigensIBA
01/2022
1Anticonvulsants (Antiepileptic Drugs)IBA
12/2021
1Cytotoxins (Cytolysins)IBA
08/2021
1Gemtuzumab (Mylotarg)FDA Link
08/2021
1Immunoconjugates (Immunoconjugate)IBA
08/2021
1ChromatinIBA
01/2021
1Bendamustine HydrochlorideFDA Link
01/2021
1Genetic Markers (Genetic Marker)IBA
01/2021
1PanobinostatIBA
11/2020
1IntegrinsIBA
01/2020
1AntimetabolitesIBA
01/2020
1Transaminases (Aminotransferases)IBA
10/2017
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
10/2017
1Histones (Histone)IBA
01/2017
1Histone Deacetylase InhibitorsIBA
01/2017
1Lysine AcetyltransferasesIBA
01/2017
1NucleotidesIBA
04/2016
1purineIBA
01/2016
1Carboxypeptidases A (Carboxypeptidase A)IBA
01/2016
1Caspase 1 (ICE Protease)IBA
06/2015
1InflammasomesIBA
06/2015
1Prednisolone (Predate)FDA LinkGeneric
06/2015
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
06/2015
1Indicators and Reagents (Reagents)IBA
04/2015
1SurvivinIBA
08/2014
1Messenger RNA (mRNA)IBA
08/2014
1EZN 3042IBA
08/2014

Therapy/Procedure

23Therapeutics
10/2022 - 01/2003
15Drug Therapy (Chemotherapy)
06/2022 - 01/2009
3Remission Induction
04/2015 - 02/2011
2Hematopoietic Stem Cell Transplantation
01/2022 - 01/2019
2Combination Drug Therapy (Combination Chemotherapy)
01/2019 - 01/2012
1Immunotherapy
12/2021
1Activities of Daily Living (ADL)
07/2021
1Heart Transplantation (Grafting, Heart)
07/2021
1Radiotherapy
11/2020
1Investigational Therapies (Experimental Therapy)
09/2017